2Rosen PP, Lesser ML,Kinne DW.Breast carcinoma at theextremes of age; comparison of patients younger than 35years and older than 75 years[J].J Surge oncology,2005,28(2):90-96.
3Lannigan AK,Going JJ,Weiller-Mitho E,et al.Mucinous breast earainoma[J].The Breast,2002,11 (3):395-361.
4iMatsud M,Yoshimoto M,Lwase T,et al.Mammographic and clinicopathological features of mucinous carcinoma of the breast [J].Breast Cancer,2007,7(1):65-70.
1[1]Sobin L H, Fleming I D, Ed. Union Internationale Contre le Cancer. TNM classification of malignant tumors[M]. 5th ed. New York: Wiley-Liss, 1997. 123-130.
2[2]Capella C, Eusebi V, Mann B, et al. Endocrine differentiation in mucoid carcinoma of the breast[J]. Histopathology, 1980, 4(6): 613-630.
3[3]Memis A,Ozdemir N,Parildar M,et al. Mucinous (colloid) breast cancer: mammographic and US features with histologic correlation[J]. Eur Radiol, 2000,35(1):39-43.
4[4]Rosen P P, Lesser M L, Kinne D W. Breast carcinoma at the extremes of age: comparison of patients younger than 35 years and older than 75 years[J]. J Surg Oncol, 1985, 28(2):90-96.
5[5]Wilson T E, Helvie M A, Oberman H A, et al. Pure and mixed mucinous carcinoma of the breast: pathologic basis for differences in mammographic appearance[J]. Am J Roentg, 1995,165(2):285-289.
6[6]Lannigan A K, Going J J,Weiler-Mitho E,et al. Mucinous breast carcinoma[J]. The Breast, 2002,11(3):359-361.
7[7]Matsuda M, Yoshimoto M, Iwase T, et al. Mammographic and clinicopathological features of mucinous carcinoma of the breast[J]. Breast Cancer, 2000, 7(1): 65-70.
8[8]Anan K, Mitsuyanma S, Tamae K, et al. Pathological features of mucinous carcinoma of the breast are favourable for breast-conserving therapy[J]. Eur J Surg Oncol, 2001,27(5): 459-463.
9[9]Anan K, Mitsuyama S, Tamae K, et al. Pathological features of mucinous carcinoma of the breast are favourable for breast-conserving therapy[J]. Eur J Surg Oncol, 2001,27(5):459-463.
10[10]Von Minckwitz G, Costa S D, et al. Maximized reduction in primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel[J]. J Clin Oncol, 1999,17(7):1999-2005.
